Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $690.48 billion, total revenue of $169.72 billion and a weighted average PE ratio of 41.20.
Market Cap
690.48B
Revenue
169.72B
Profits
16.76B
PE Ratio
41.20
Profit Margin
9.87%
Dividend Yield
0.24%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 185.59B | -0.47% | 374,903 | 44.56B |
| 2 | DHR | Danaher Corporation | 138.63B | 0.28% | 744,706 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 47.94B | -1.05% | 91,987 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 32.44B | -0.25% | 737,373 | 7.07B |
| 5 | IQV | IQVIA Holdings Inc. | 29.75B | 1.57% | 434,620 | 16.31B |
| 6 | WAT | Waters Corporation | 29.46B | -0.73% | 234,185 | 3.17B |
| 7 | NTRA | Natera, Inc. | 28.14B | 0.22% | 497,241 | 2.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 24.53B | -0.24% | 28,578 | 4.03B |
| 9 | LH | Labcorp Holdings Inc. | 22.03B | -0.85% | 94,680 | 13.95B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.69B | -0.91% | 128,062 | 11.04B |
| 11 | EXAS | Exact Sciences Corporation | 19.74B | -0.09% | 1,075,878 | 3.25B |
| 12 | ILMN | Illumina, Inc. | 18.92B | -0.68% | 353,505 | 4.34B |
| 13 | MEDP | Medpace Holdings, Inc. | 13.46B | 0.82% | 69,500 | 2.53B |
| 14 | GH | Guardant Health, Inc. | 11.75B | -1.75% | 367,145 | 982.02M |
| 15 | RVTY | Revvity, Inc. | 10.13B | -0.84% | 189,942 | 2.86B |
| 16 | QGEN | Qiagen N.V. | 8.89B | -3.16% | 658,694 | 2.09B |
| 17 | CRL | Charles River Laboratories International, Inc. | 8.57B | -0.17% | 97,148 | 4.02B |
| 18 | ICLR | ICON Public Limited Company | 8.16B | -0.26% | 289,930 | 8.10B |
| 19 | RDNT | RadNet, Inc. | 4.75B | 0.96% | 279,890 | 2.04B |
| 20 | SHC | Sotera Health Company | 4.08B | -2.05% | 1,543,128 | 1.16B |
| 21 | BLLN | BillionToOne, Inc. | 3.15B | -6.37% | 128,113 | 305.11M |
| 22 | TWST | Twist Bioscience Corporation | 2.77B | -3.77% | 286,511 | 391.56M |
| 23 | VCYT | Veracyte, Inc. | 2.67B | -0.69% | 209,045 | 517.15M |
| 24 | WGS | GeneDx Holdings Corp. | 2.67B | 3.28% | 115,013 | 427.54M |
| 25 | NEOG | Neogen Corporation | 2.01B | -4.54% | 707,983 | 880.32M |
| 26 | GRAL | GRAIL, Inc. | 1.91B | -5.59% | 545,904 | 147.17M |
| 27 | NEO | NeoGenomics, Inc. | 1.14B | -1.67% | 222,021 | 727.33M |
| 28 | CDNA | CareDx, Inc. | 904.48M | -1.29% | 91,460 | 379.81M |
| 29 | OPK | OPKO Health, Inc. | 876.72M | -2.12% | 440,276 | 606.88M |
| 30 | PSNL | Personalis, Inc. | 809.85M | -1.28% | 530,490 | 69.65M |
| 31 | CSTL | Castle Biosciences, Inc. | 786.98M | -2.40% | 85,373 | 344.23M |
| 32 | MYGN | Myriad Genetics, Inc. | 459.13M | -4.66% | 884,773 | 824.50M |
| 33 | FLGT | Fulgent Genetics, Inc. | 458.47M | 0.34% | 197,269 | 322.67M |
| 34 | PRE | Prenetics Global Limited | 308.47M | 2.98% | 105,244 | 92.39M |
| 35 | BNR | Burning Rock Biotech Limited | 238.37M | -0.49% | 2,036 | 75.75M |
| 36 | BDSX | Biodesix, Inc. | 185.39M | 0.13% | 78,587 | 88.50M |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 174.28M | -0.59% | 2,343 | 4.40M |
| 38 | MDXH | MDxHealth SA | 171.56M | 2.14% | 22,639 | 107.88M |
| 39 | FONR | FONAR Corporation | 121.37M | 0.13% | 14,871 | 106.03M |
| 40 | XGN | Exagen Inc. | 74.79M | 0.30% | 34,889 | 63.60M |
| 41 | PRPO | Precipio, Inc. | 45.46M | -2.20% | 9,695 | 22.80M |
| 42 | MBAI | Check-Cap Ltd. | 14.36M | 10.67% | 54,188 | - |
| 43 | NOTV | Inotiv, Inc. | 12.77M | 0.60% | 200,484 | 514.03M |
| 44 | MYNZ | Mainz Biomed N.V. | 8.78M | -2.02% | 59,171 | 659.94K |
| 45 | XWEL | XWELL, Inc. | 7.87M | 3.41% | 141,641 | 29.52M |
| 46 | ADVB | Advanced Biomed Inc. | 6.25M | 2.69% | 22,309 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 4.54M | -2.88% | 18,924 | 6.78M |
| 48 | NDRA | ENDRA Life Sciences Inc. | 4.01M | 2.38% | 12,652 | - |
| 49 | ISPC | iSpecimen Inc. | 2.38M | -2.17% | 278,152 | 3.35M |